SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-08-000372
Filing Date
2008-06-17
Accepted
2008-06-16 18:51:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT cyto0608a2.txt SC 13G/A 10401
  Complete submission text file 0001172661-08-000372.txt   12253
Mailing Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540
Business Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Subject) CIK: 0000725058 (see all company filings)

IRS No.: 222322400 | State of Incorp.: DE | Fiscal Year End: 0508
Type: SC 13G/A | Act: 34 | File No.: 005-37931 | Film No.: 08901585
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A